G2MC Flagship Projects
Pharmacogenomics
Developing strategies for implementing pharmacogenomics data and best practices into clinical use.
G2MC Flagship Projects
Pharmacogenomics
Developing strategies for implementing pharmacogenomics data and best practices into clinical use.
Co-Leads
George Patrinos (Greece)
Mission
The Pharmacogenomics Flagship Project aims to develop strategies for the collection, storing, and sharing of pharmacogenomics (PGx) data, as well as develop and implement PGx best practices for clinical use.
Goals
- Develop data repositories of PGx variants in diverse populations around the world.
- Develop a strategy to engage PIs and young investigators from low and middle-income countries in PGx research and clinical implementation.
- The Pharmacogenomics Flagship Project is focusing efforts on the need for generating harmonized guidelines for pharmacogenomics in clinical use – an area that is already under exploration but can potentially be advanced further through the efforts of the flagship project group.
- Project leads and members are exploring opportunities to collaborate with the Evidence Working Group on methods for demonstrating existing evidence in the field of pharmacogenomics.
Genome-informed drug use for cardiovascular diseases in the UAE: The first prospective PGx clinical study in the Middle East and SE Asia
G2MC co-chair, George P. Patrinos, is co-leading a project aimed to address the major challenges and obstacles for the implementation of point-of-care pharmacogenomics testing in patient care in the United Arab Emirates (UAE).
G2MC Flagship Project Updates
Read the latest updates on initiatives being carried out by G2MC’s flagship projects, including an overview of actions moving forward and how members can get involved.